Candesartan cilexetil

ADVERTISEMENT

Identification

Molecular formula
C33H34N6O6
CAS Number
145040-37-5
IUPAC Name
1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
Molecular Weight
610.66g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3600g/cm3
Synonyms
Candesartan cilexetil
Interesting facts

Interesting Facts about 1-(Cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate

This compound, often referred to in scientific discussions as a specialized organic molecule, showcases an intricate structure that is a fusion of various chemical functionalities. Here are some compelling points regarding this compound:

  • Diverse Functional Groups: This molecule features an array of functional groups, including ethoxy, carbonyloxy, and tetrazole, which all contribute to its unique chemical behavior and potential applications in medicinal chemistry.
  • Pharmacological Potential: The presence of the tetrazole ring has been linked to various biological activities, making this compound a subject of interest in drug discovery processes. Tetrazoles are often used in the development of pharmaceuticals due to their ability to enhance bioavailability.
  • Synergistic Interactions: The combination of the benzimidazole core with other aromatic systems may result in synergistic effects that could modify the compound's efficacy in biological contexts, potentially impacting its pharmacodynamics and pharmacokinetics.

Researchers are continually interested in exploring the intricate interactions of such compounds, especially in fields such as:

  • Medicinal Chemistry
  • Drug Design and Development
  • Agricultural Chemistry

As stated by renowned chemist Robert H. Grubbs, “The best way to prepare for the future is to invent it.” This sentiment resonates with the exploration of complex molecules like this one, which hold promise for fostering innovation in therapy and treatment methodologies.

Continued investigation into the biological activities and synthesis routes of compounds like 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate may unlock potential breakthroughs in the pharmaceutical sector.

ADVERTISEMENT